DAPK1 rs4877365: What Your Genotype Means
The rs4877365 variant is a single nucleotide polymorphism located within the DAPK1 gene. It has been extensively studied for potential associations with late-onset Alzheimer's disease, though research findings remain inconsistent across different populations.
What each genotype means
Baseline DAPK1 expression
This genotype represents one of the common variations in the DAPK1 gene. Research has investigated this variant for potential associations with late-onset Alzheimer's disease, though findings regarding the specific impact of this genotype remain subject to ongoing scientific study and may vary by ancestry.
This genotype is common in many global populations, consistent with the reported minor allele frequency of approximately 0.32 for the variant.
Baseline DAPK1 expression
This genotype represents a heterozygous state for the DAPK1 variant. Studies have linked variations in this gene to potential differences in allele-specific expression, which may modulate susceptibility to neurodegenerative conditions like Alzheimer's disease, though the clinical significance is not definitive.
This genotype is frequently observed across diverse populations, reflecting the common nature of this genetic variant.
Baseline DAPK1 expression
This genotype is one of the common configurations for this DAPK1 variant. While some research has identified associations between DAPK1 genetic variation and Alzheimer's disease risk, these associations are complex and influenced by multiple genetic and environmental factors; this result should not be interpreted as a diagnostic indicator.
This genotype is found in a significant portion of the population, consistent with the global frequency of the variant alleles.
Understanding the rs4877365 Variant
The rs4877365 variant is a specific change in the DNA sequence located within the DAPK1 gene on chromosome 9. In genetics, a single nucleotide polymorphism (SNP) like rs4877365 represents a variation at a single position in the genome. This particular variant is found within the intronic regions of the gene, meaning it does not directly alter the protein-coding sequence of the DAPK1 protein. However, research suggests that this variant may influence how the DAPK1 gene is expressed, potentially affecting the amount of protein produced in specific tissues. Because it is located in a non-coding region, its primary impact is thought to be regulatory rather than structural. Scientists often study such variants to understand how subtle changes in gene regulation might contribute to complex health conditions over time.
The Role of the DAPK1 Gene
The DAPK1 gene encodes a protein known as Death-Associated Protein Kinase 1. This protein functions as a regulator of apoptosis, which is the process of programmed cell death, and autophagy, a cellular mechanism for cleaning out damaged components. By controlling these pathways, DAPK1 plays a critical role in maintaining cellular health and responding to stress. Because the brain is highly sensitive to cellular stress and the accumulation of damaged proteins, researchers have long hypothesized that variations in genes like DAPK1 could influence neurodegenerative processes. When DAPK1 activity is dysregulated, it may impact how neurons survive or die under pathological conditions. Understanding this gene's function is a major area of interest in neurobiology, as it provides a potential target for therapeutic interventions aimed at protecting neuronal health.
Research and Associations
The association between rs4877365 and late-onset Alzheimer's disease (LOAD) has been a subject of significant scientific debate. Early studies identified a potential link, suggesting that this variant might influence disease susceptibility. However, subsequent research has produced conflicting results. While some studies in specific cohorts have reported a statistical association, others have failed to replicate these findings in different populations, such as European or Italian groups. Furthermore, investigations into whether this variant contributes to Parkinson's disease have generally yielded negative results, showing no clear evidence of an increased risk. The current scientific consensus is that the evidence for rs4877365 as a major risk factor is limited and inconsistent. These discrepancies highlight the complexity of genetic associations, where results can vary significantly based on the ancestry of the study participants and the specific environmental context.
Population Frequency
The rs4877365 variant is a common genetic marker. Global data indicates that the minor allele frequency is approximately 0.32, meaning it is present in a significant portion of the population. Because it is a common variant, it is found across diverse ancestral groups, though the frequency of the specific alleles can fluctuate between different geographic and ethnic populations. This high frequency is one reason why it has been a frequent candidate for large-scale genetic association studies. However, the prevalence of the variant does not necessarily correlate with its clinical impact, as many common variants have neutral effects on health. Researchers continue to monitor these frequencies to better understand the genetic architecture of human populations and to refine the statistical power of future association studies.
Interpreting Your Genetic Information
It is important to understand that having a specific genotype for rs4877365 does not provide a medical diagnosis or a definitive prediction of future health. Genetic associations, especially those with limited or mixed evidence like this one, are statistical observations made at the population level and cannot be applied to predict individual outcomes. Many factors, including lifestyle, environment, and other genetic variants, contribute to the risk of complex conditions like Alzheimer's disease. If you have questions about your genetic results or concerns regarding your neurological health, you should consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your information in the context of your personal and family medical history. Never use genetic data to make independent medical decisions or to alter any prescribed treatments without professional guidance.
How common is this variant?
The global minor allele frequency for rs4877365 is approximately 0.32, making it a common variant across diverse human populations.
Frequently asked questions
Is rs4877365 a cause of Alzheimer's disease?
No, rs4877365 is not considered a cause of Alzheimer's disease. While some studies have explored a statistical association, the evidence is inconsistent and does not establish a direct causal link.
Should I be worried if I have the T allele?
There is no reason for concern based on this variant alone. Genetic associations for complex diseases are often weak and inconsistent, and this variant is common in the general population.
Does this variant affect Parkinson's disease risk?
Current research has not found evidence to support an association between rs4877365 and an increased risk of Parkinson's disease. Studies across multiple populations have consistently shown no significant link.
Can I use this information to predict my health?
No, this information cannot be used to predict your health. Genetic variants like rs4877365 are only one small part of a very complex picture that includes many other genes and environmental factors.
Sources & further reading
Educational information only, last refreshed 10/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4877365?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29